USPTO serial 98270863
PRECISION MEDICAL MODELING
Reviewed by CopyMark Law Group
Status 641Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- NIEMANN, SHELBY LYNN
- Law office
- TMO LAW OFFICE 100
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with PRECISION MEDICAL MODELING?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Nicole Kinsely, Esq.
Nicole Kinsely, Esq. FOLEY HOAG LLP155 SEAPORT BOULEVARDBOSTON, MA 02210United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Software as a service (SaaS) services featuring software for collecting, managing, and analyzing pharmaceutical data, biologic data, medical device data, and clinical trial data; Providing medical and scientific research information in the field of pharmaceuticals, biologic preparations, medical devices, and clinical trials; Software as a service (SAAS) services featuring software for matching cancer patients with appropriate therapeutic options, approved treatments, and clinical trials; Software as a service (SaaS) services featuring software for use in database management in the field of pharmaceuticals, biologic preparations, medical devices, and clinical trials; Software as a service (SaaS) services featuring software for management of clinical trials, namely, for planning clinical trials, identifying and recruiting patients for participation in clinical trials, and matching patients with clinical trials; Providing pharmaceutical data, biologic data, medical device data, clinical trial data, and patient data, and analysis of such data, all for pharmaceutical research and development | ACTIVE | — |
| 044 | Providing on-line medical record analysis services designed to provide patients with custom tailored information about the range of possible therapies available, through medication, biologic preparations, medical devices, and clinical trials, for a defined set of symptoms, diagnoses, and biological attributes; providing medical information in the field of pharmaceuticals, biologic preparations, medical devices, and clinical trials | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 4, 2024 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Oct 4, 2024 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Aug 21, 2024 | LOPT | LETTER OF PROTEST EVIDENCE FORWARDED | — |
| Jul 10, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 10, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 10, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 20, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 20, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 18, 2023 | NWAP | NEW APPLICATION ENTERED | — |